Todd Pesavento is a Nephrology physician affiliated with The Ohio State University. OpenAlex indexes 116 publications with 3,475 citations (h-index 30).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
410 W 10th Ave
Columbus, OH 432101240
Telephone
614-293-7677Provider last certified this registry record 12 Sept 2025.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Travere Therapeutics, Inc.Program year20251 payment
- ARGENX US, INC.Program year20248 payments
- SANOFI-AVENTIS U.S. LLCProgram year20235 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
63.3%Short-acting sulfonamides61%Sulfamethoxazole-Trimethoprim100%Part D≥134 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor1.3%Valganciclovir Hcl100%Part D<11 patients+ 1 more class in this area
Cardiovascular
18.7%Beta blocker5.3%Carvedilol53%Metoprolol Succinate30%Metoprolol Tartrate18%Part D<11 patientsCalcium channel blocker4.8%Nifedipine Er73%Amlodipine Besylate27%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
9.2%Corticosteroid7.5%Prednisone100%Part D≥26 patientsProton pump inhibitor1.7%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2007–2008 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A review of kidney transplantation from HCV-viremic donors into HCV-negative recipients
Kidney International
2021 - Early Posttransplant Blood Transfusion and Risk for Worse Graft Outcomes
Kidney International Reports
2021 - A New Panel-Estimated GFR, Including β2-Microglobulin and β-Trace Protein and Not Including Race, Developed in a Diverse Population
American Journal of Kidney Diseases
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Jennifer Woyach, MD
The Ohio State University
Uma Borate, MD
The Ohio State University
Sooyoung Kim
The Ohio State University
Jay Zweier, MD
The Ohio State University
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”